Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Pharmacological Research
|
May 15, 2025
Ferroportin 1 depletion in neural stem cells promotes hippocampal neurogenesis and cognitive function in mice
Yiqian Ding, Shanshan Yao, Shuxin Guo, et al.
Viruses
|
June 24, 2022
A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection
Dian Zeng, Jiabao Xin, Kunyu Yang, et al.
Leukemia Research
|
September 16, 2022
Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy
Yanhua Yue, Yang Cao, Fei Wang, et al.
Leukemia Research
|
April 18, 2023
Corrigendum to "Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy" [Leuk. Res. 122 (2022) 106949]
Yanhua Yue, Yang Cao, Fei Wang, et al.
Cell Discovery
|
July 28, 2023
Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine
Shuxin Guo, Yuxuan Zheng, Zhengrong Gao, et al.
Journal of Immunology Research
|
March 27, 2023
Vascular Normalization Was Associated with Colorectal Tumor Regression upon Anti-PD-L1 Combinational Therapy
Yan Zhang, Jiayan Gao, Yan He, et al.
Frontiers in Oncology
|
August 22, 2022
Novel myeloma patient-derived xenograft models unveil the potency of anlotinib to overcome bortezomib resistance
Yanhua Yue, Yang Cao, Xunyuan Mao, et al.
Theranostics
|
January 22, 2019
An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency
Chenguang Shen, Minwei Zhang, Yuanzhi Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 18, 2023
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2
Xia Rao, Runchu Zhao, Zhou Tong, et al.
Cell
|
May 14, 2022
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
Kun Xu, Ping Gao, Sheng Liu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Pharmacological Research
|
May 15, 2025
Ferroportin 1 depletion in neural stem cells promotes hippocampal neurogenesis and cognitive function in mice
Yiqian Ding, Shanshan Yao, Shuxin Guo, et al.
Viruses
|
June 24, 2022
A Hemagglutinin Stem Vaccine Designed Rationally by AlphaFold2 Confers Broad Protection against Influenza B Infection
Dian Zeng, Jiabao Xin, Kunyu Yang, et al.
Leukemia Research
|
September 16, 2022
Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy
Yanhua Yue, Yang Cao, Fei Wang, et al.
Leukemia Research
|
April 18, 2023
Corrigendum to "Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy" [Leuk. Res. 122 (2022) 106949]
Yanhua Yue, Yang Cao, Fei Wang, et al.
Cell Discovery
|
July 28, 2023
Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine
Shuxin Guo, Yuxuan Zheng, Zhengrong Gao, et al.
Journal of Immunology Research
|
March 27, 2023
Vascular Normalization Was Associated with Colorectal Tumor Regression upon Anti-PD-L1 Combinational Therapy
Yan Zhang, Jiayan Gao, Yan He, et al.
Frontiers in Oncology
|
August 22, 2022
Novel myeloma patient-derived xenograft models unveil the potency of anlotinib to overcome bortezomib resistance
Yanhua Yue, Yang Cao, Xunyuan Mao, et al.
Theranostics
|
January 22, 2019
An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency
Chenguang Shen, Minwei Zhang, Yuanzhi Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 18, 2023
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2
Xia Rao, Runchu Zhao, Zhou Tong, et al.
Cell
|
May 14, 2022
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
Kun Xu, Ping Gao, Sheng Liu, et al.
Page
of 2